The Thomson Reuters’ Post-Venture Capital Index (PVCI) saw an incremental climb of 6.36 points to end June at 1116.48, a 0.57 percent gain from the 1110.12 mark at the end of May.
The index value for the end of June is a gain of more than 150 points, or 15.5 percent, since the start of the year when the PVCI stood at 966.
The Nasdaq dipped slightly in June by about 18 points, while the S&P inched upwards by 6 points.
At the end of June, the PVCI was comprised of 347 companies. Of the stocks tracked, 213 advanced in value during the month while 134 declined. The number of companies in the index rises and falls, depending on new issues or as the companies fold or are acquired. Also, companies remain in the index for only 10 years.
A total of 51 of the advancing stocks in June were in biotech, while computer software and services saw 45 stocks rise. The largest group of decliners was also in computer software and services with 32, followed by biotech with 24 decliners.
Facebook, as it typically does each month, ranked as the company with top market value, as of June 30, followed by Tesla and Kinder Morgan.
The PVCI measures the performance of public stocks, tracking venture-backed companies beginning at the time when they go public.
The index is calculated daily and does not take into account dividends.
It began in January 1986 with an initialized index value of 100.
Download Data: PVCI as of June 30, 2017
Photo of financial concept with U.S. currency courtesy of Avosb/iStock/Getty Images